We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+67.85%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$3B
AUM Growth
+$1.23B
Cap. Flow
+$649M
Cap. Flow %
21.63%
Top 10 Hldgs %
17.27%
Holding
1,306
New
485
Increased
132
Reduced
163
Closed
412

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$6.08M
2
EHC icon
Encompass Health
EHC
+$5.83M
3
BC icon
Brunswick
BC
+$5.57M
4
BBWI icon
Bath & Body Works
BBWI
+$5.29M
5
GE icon
GE Aerospace
GE
+$5.21M

Sector Composition

Rank Sector Weight
1 Healthcare 4.18%
2 Consumer Discretionary 4.17%
3 Technology 2.63%
4 Energy 0.9%
5 Industrials 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBBY
601
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
$742K 0.02%
+70,000
New +$482K
HEXO
602
CALL
DELISTED
HEXO Corp. Common Shares
HEXO
$738K 0.02%
+17,857
New +$646K
ZYNE
603
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$734K 0.02%
218,000
+208,800
+2,270% +$987K
RIG icon
604
CALL
Transocean
RIG
$5.89B
$733K 0.02%
400,000
ADAP
605
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$732K 0.02%
+73,200
New +$460K
EOLS icon
606
PUT
Evolus
EOLS
$385M
$732K 0.02%
+138,200
New +$637K
LUMN icon
607
Lumen
LUMN
$6.57B
$730K 0.02%
72,800
-30,600
-30% -$306K
PZZA icon
608
Papa John's
PZZA
$984M
$729K 0.02%
9,174
-3,326
-27% -$247K
XRX icon
609
PUT
Xerox
XRX
$387M
$729K 0.02%
47,700
-1,000
-2% -$17.3K
ADPT icon
610
CALL
Adaptive Biotechnologies
ADPT
$3.59B
$726K 0.02%
15,000
COLD icon
611
Americold
COLD
$4.02B
$726K 0.02%
+20,000
New +$683K
SMSI icon
612
CALL
Smith Micro Software
SMSI
$14.5M
$722K 0.02%
4,050
-5,730
-59% -$1.04M
HPE icon
613
Hewlett Packard
HPE
$63.4B
$721K 0.02%
+74,200
New +$729K
CTRN icon
614
Citi Trends
CTRN
$555M
$719K 0.02%
+35,566
New +$466K
OSG
615
CALL
Octave Specialty Group
OSG
$243M
$717K 0.02%
+50,000
New +$731K
GBT
616
DELISTED
Global Blood Therapeutics, Inc.
GBT
$717K 0.02%
+11,370
New +$780K
CXO
617
DELISTED
CONCHO RESOURCES INC.
CXO
$708K 0.02%
+13,770
New +$761K
FLR icon
618
PUT
Fluor
FLR
$7.01B
$706K 0.02%
58,400
+5,300
+10% +$55.6K
UAA icon
619
Under Armour
UAA
$2.84B
$701K 0.02%
72,000
+15,626
+28% +$148K
CVE icon
620
CALL
Cenovus Energy
CVE
$55.7B
$700K 0.02%
+150,000
New +$577K
IVZ icon
621
CALL
Invesco
IVZ
$13.1B
$694K 0.02%
+64,500
New +$579K
IVZ icon
622
PUT
Invesco
IVZ
$13.1B
$694K 0.02%
+64,500
New +$579K
ONB icon
623
CALL
Old National Bancorp
ONB
$10.2B
$689K 0.02%
+50,000
New +$675K
AKBA icon
624
Akebia Therapeutics
AKBA
$354M
$678K 0.02%
50,000
+10,000
+25% +$103K
SLG icon
625
SL Green Realty
SLG
$3.76B
$675K 0.02%
+14,142
New +$649K

Similar funds

Caption Management's Q2 2020 Portfolio in Review

As of Q2 2020, Caption Management held 1,306 positions worth $3B, up 70% from $1.77B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Caption Management deployed $649M of net new capital in Q2 2020, opening 485 new positions and adding to 132 existing holdings. Its largest new stake was SolarEdge: 148,183 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 4.2% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Caesars Entertainment, an estimated $6.08M trimmed.

  • Caption Management's largest Q2 2020 buy was SolarEdge: 148,183 shares worth $20.6M.
  • Caption Management added most to Wayfair in Q2 2020, an estimated $18.1M increase.
  • Caption Management's biggest Q2 2020 reduction was Caesars Entertainment, cutting an estimated $6.08M.
  • Caption Management fully exited Encompass Health in Q2 2020, selling an estimated $5.83M.
  • Caption Management's ten largest holdings make up 17% of its $3B portfolio in Q2 2020.
  • Caption Management opened 485 new positions and closed 412 in Q2 2020.
  • Caption Management's portfolio value rose 70% quarter-over-quarter to $3B.

Based on Caption Management's 13F filing for Q2 2020, filed 14 Aug 2020.